Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • E3 Ligase Ligand-Linker Conjugates
    (2)
  • Akt
    (1)
  • Antibody-Drug Conjugates (ADCs)
    (1)
  • Bcr-Abl
    (1)
  • DNA/RNA Synthesis
    (1)
  • ERK
    (1)
  • Epigenetic Reader Domain
    (1)
  • Kras
    (1)
  • PKA
    (1)
  • Others
    (5)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FCM
    (1)
  • Functional assay
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (7)
  • Nervous System
    (2)
  • Immune System
    (1)
  • Inflammation
    (1)
  • Respiratory System
    (1)
Filter
Search Result
Results for "

T3973

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    9
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
  • PROTAC Products
    3
    TargetMol | PROTAC
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
PF-CBP1
T39731962928-21-7
PF-CBP1 HCl is a highly selective inhibitor of the bromodomain of CREB-binding protein(CREBBP). It inhibits CREBBP (IC50: 125 nM) and p300 bromodomains (IC50: 363 nM).
  • $46
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Datopotamab deruxtecan
S-1062a, DS-1062, DS1062, Dato-DXd
T397302238831-60-0
Datopotamab deruxtecan (DS-1062) is an antibody-drug conjugate (ADC) that targets tropomyosin 2 (TROP2) on the surface of trophoblast cells. Datopotamab deruxtecan exhibits antitumor activity by specifically binding to TROP2 and internalizing, releasing DXd to inhibit topoisomerase I (IC₅₀ = 0.31 μM), thereby inducing DNA damage and apoptosis. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.
  • $1,060
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Hu7691 free base
T397332241232-43-7In house
Hu7691 free base is an orally active, potent, and selective Akt inhibitor with anti-proliferative and neurogenic effects on various neuroblastoma cell lines. It inhibits Akt1, Akt2, and Akt3, and induces differentiation of neuroblastoma cells.
  • $293
In Stock
Size
QTY
Bersiporocin
DWN12088, DWN 12088
T397392241808-52-4In house
Bersiporocin is a novel prolyl-tRNA synthetase (PRS) inhibitor that exerts antifibrotic effects through downregulation of collagen synthesis and is well tolerated in the clinic. In cellular and animal models of idiopathic pulmonary fibrosis (IPF), DWN12088 significantly reduced collagen synthesis and improved lung function.
  • $283
In Stock
Size
QTY
BCR-ABL-IN-3
T397322240191-12-0
BCR-ABL-IN-3 is a highly effective, irreversible inhibitor of Bcr-Abl, with an IC50 value of ≤100 nM for Ba/F3 Bcr-Abl T3151, displaying significant anti-cancer activity.
  • $970
Inquiry
Size
QTY
(S,R,S)-AHPC-PEG1-NH2
VH032-PEG1-NH2, (S,R,S)-AHPC-PEG1-NH2
T397352241641-57-4
(S,R,S)-AHPC-PEG1-NH2 (VH032-PEG1-NH2) is a synthesized conjugate that combines a VH032-based VHL ligand with a linker for use in PROTAC technology, functioning as an E3 ligase ligand-linker.
  • Inquiry Price
Inquiry
Size
QTY
(S,R,S)-AHPC-C2-NH2
(S,R,S)-AHPC-C2-NH2
T397362241643-69-4
(S,R,S)-AHPC-C2-NH2 is a synthesized conjugate that combines the VH032-based VHL ligand with a linker, designed for use in PROTAC technology as an E3 ligase ligand-linker.
  • $1,520
Inquiry
Size
QTY
NH2-PEG5-C6-Cl hydrochloride
NH2-PEG5-C6-Cl hydrochloride
T397372241669-16-7
NH2-PEG5-C6-Cl hydrochloride is a polyethylene glycol (PEG)-based linker compound, commonly used in the synthesis of proteolysis targeting chimeras (PROTACs).
  • Inquiry Price
7-10 days
Size
QTY
ASP2453
T397382241719-73-1
ASP2453 is a potent, selective, and covalent inhibitor of KRAS G12C that inhibits the Son of Sevenless (SOS)-mediated interaction between KRAS G12C and Raf with an IC50 value of 40 nM.
  • $118
In Stock
Size
QTY